Eva Wolf (E Wolf)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Men Who Have Sex With Men

Top Venues

AIDS research and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Hoffmann, Heiko Jessen, Christoph Wyen, Stephan Grunwald, Sebastian Noe, Jörn Teichmann, Anja-Sophie Krauss, Henning Kolarikal, Stefan Scholten, Christoph Schuler, Markus Bickel, Clemens Roll, Peter Kreckel, Siegfried Köppe, Matthias Straub, Gerd Klausen, Johannes Lenz, Stefan Esser, Björn Jensen, Michael Rausch, Stefan Unger, Ramona Pauli, Georg Härter, Matthias C Mueller, Anja Masuhr, Guido Schäfer, Ulrich Seybold, Sven Schellberg, Jochen Schneider, Malte Benedikt Monin, Eva Wolf, Christoph D Spinner, Christoph Boesecke
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany. HIV medicine (2022)
Eva Wolf, Christoph Boesecke, Annamaria Balogh, Helen Bidner, Christiane Cordes, Hans Heiken, Ivanka Krznaric, Tim Kümmerle, Hans-Jürgen Stellbrink, Jochen Schneider, Christoph D Spinner, null null
Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance. AIDS research and therapy 18 (1) (2021)
Antonella d'Arminio Monforte, F Bonnet, Heiner C Bucher, Valérie Pourcher, Nikos Panatzis, Annegret Pelchen-Matthews, Giota Touloumi, Eva Wolf
What do the changing patterns of comorbidity burden in people living with HIV mean for long-term management? Perspectives from European HIV cohorts. HIV medicine (2021)
Christian Hoffmann, Eva Wolf
Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA and Canada. Infection 49 (1) (2020)
Markus Bickel, Christian Hoffmann, Eva Wolf, Axel Baumgarten, Christoph Wyen, Christoph D Spinner, Hans Jäger, Nils Postel, Stefan Esser, Markus Mueller, Albrecht Stoehr, Stefan Preis, Stephan Klauke, Knud Schewe, null null
High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study. Infection 48 (3) (2020)